Delhi: Centre flags anomalies in identification of vaccine beneficiaries

Vaccination exercise as a tool to protect the most vulnerable population groups in the country from Covid-19 continues to be regularly reviewed and monitored at the highest level, says govt

Satyendar Jain
Delhi Health Minister Satyendar Jain
BS Web Team New Delhi
2 min read Last Updated : Apr 05 2021 | 7:43 PM IST
The union government on Monday wrote to the Delhi government, pointing to irregularities in the identification of Covid vaccination beneficiaries, below the age of 45 years, by some private vaccination centres, according to an official statement.

In a letter addressed to the Principal Secretary (Health), of Delhi government, the union health ministry pointed out that there have been serious lapses in registration of beneficiaries by the VIMHANS (Vidyasagar Institute of Mental Health, Neuro and Allied Sciences) located at Nehru Nagar area in the North East District of Delhi, operating as a Private Covid Vaccination Centre.

VIMHANS has been found to register beneficiaries below the age of 45 years as health care workers (HCWs) and front line workers (FLWs), and vaccinate them.

Centre asked the Delhi administration to immediately issue a show cause notice to VIMHANS regarding such wrong practices which violate Covid-19 vaccination norms, and seek a written explanation from them within the next 48 hours.

"Appropriate monetary fine may also be imposed on the hospital. Further, it has been suggested that depanelment of the Hospital may be considered if the explanation to the show cause notice is found unsatisfactory," said the ministry of health.

"The vaccination exercise as a tool to protect the most vulnerable population groups in the country from Covid-19 continues to be regularly reviewed and monitored at the highest level," it said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineDelhi governmentHealth Ministry

Next Story